The report provides value (USD million) data for all the industry categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides industry player shares and distribution shares data for each of the aforementioned industry categories. The report is supplemented with global corporate-level profiles of the key industry participants.


Scope of the Research

- Countries covered include Argentina, Brazil and Mexico.
- Industry size and market share data for Drug Delivery Devices industry categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections.
- Annualized industry revenues (USD million) data for each of the industry categories in each of the country. Data from 2003 to 2010, projection forward for 7 years to 2017.
- 2010 industry player shares and distribution shares data for each of the industry categories and countries.
- Global corporate-level profiles of key industry players operating within the South and Central America Drug Delivery Devices industry ..
- Key Companies covered include GlaxoSmithKline plc, AstraZeneca PLC, Boehringer Ingelheim GmbH, Baxter International Inc., Hospira, Inc., B. Braun Melsungen AG and others.

Reasons to buy

- Develop innovative strategies by selecting the key market segment expected to grow .
- Develop successful market-entry strategies .
- Understand and respond to your competition by identifying who-stands-where in the South and Central America Drug Delivery Devices competitive landscape.
- Facilitate better investment decision making by identifying the key industry sectors expected to register strong growth in the near future.
- What are the best distribution channels and what’s the most preferred mode of product distribution – Identify, understand and decide.

Table Of Contents

1 Table of Contents

I Table of Contents 2
I. 1 List of Data tables 6
I. 2 List of Charts 8

II Introduction 10
II. 1 About this Report and the Author 10

III Drug Delivery Devices in South and Central America 11
III. 1 Drug Delivery Devices Cross Country Comparison, Sales (USD Million), from 2003 to 2017 11
III. 2 Drug Delivery Devices, South and Central America, Overall Sales (USD Million), from 2003 to 2017 12
III. 3 Drug Delivery Devices, South and Central America, Segment Volume (Units), from 2003 to 2017 19
III. 4 Drug Delivery Devices, South and Central America, Firms share (2009-2010) 24

IV Drug Delivery Devices In Argentina 26
IV. 1 Drug Delivery Devices, Argentina, Overall Sales (USD Million), from 2003 to 2017 26
IV. 2 Drug Delivery Devices, Argentina, Segment Volume (Units), from 2003 to 2017 32
IV. 3 Drug Delivery Devices, Argentina, Distribution Channel (2009-2010) 37
IV. 3.1 Central Venous Catheters, Argentina, Distribution Channel (2009-2010) 37
IV. 3.2 Infusion Systems, Argentina, Distribution Channel (2009-2010) 37
IV. 3.3 Metered Dose Inhaler Devices, Argentina, Distribution Channel (2009-2010) 38
IV. 3.4 Needle Free Injections, Argentina, Distribution Channel (2009-2010) 38
IV. 4 Drug Delivery Devices, Argentina, Market Shares (2009-2010) 39
IV. 4.1 Drug Delivery Devices, Argentina, Market Shares (2009-2010) 39
IV. 4.2 Central Venous Catheters, Argentina, Market Shares (2009-2010) 41
IV. 4.3 Infusion Systems, Argentina, Market Shares (2009-2010) 43
IV. 4.4 Metered Dose Inhaler Devices, Argentina, Market Shares (2009-2010) 45
IV. 4.5 Needle Free Injections, Argentina, Market Shares (2009-2010) 47

V Drug Delivery Devices In Brazil 48
V. 1 Drug Delivery Devices, Brazil, Overall Sales (USD Million), from 2003 to 2017 48
V. 2 Drug Delivery Devices, Brazil, Segment Volume (Units), from 2003 to 2017 54
V. 3 Drug Delivery Devices, Brazil, Distribution Channel (2009-2010) 59
V. 3.1 Central Venous Catheters, Brazil, Distribution Channel (2009-2010) 59
V. 3.2 Infusion Systems, Brazil, Distribution Channel (2009-2010) 59
V. 3.3 Metered Dose Inhaler Devices, Brazil, Distribution Channel (2009-2010) 60
V. 3.4 Needle Free Injections, Brazil, Distribution Channel (2009-2010) 60
V. 4 Drug Delivery Devices, Brazil, Market Shares (2009-2010) 61
V. 4.1 Drug Delivery Devices, Brazil, Market Shares (2009-2010) 61
V. 4.2 Central Venous Catheters, Brazil, Market Shares (2009-2010) 63
V. 4.3 Infusion Systems, Brazil, Market Shares (2009-2010) 65
V. 4.4 Metered Dose Inhaler Devices, Brazil, Market Shares (2009-2010) 67
V. 4.5 Needle Free Injections, Brazil, Market Shares (2009-2010) 68

VI Drug Delivery Devices In Mexico 69
VI. 1 Drug Delivery Devices, Mexico, Overall Sales (USD Million), from 2003 to 2017 69
VI. 2 Drug Delivery Devices, Mexico, Segment Volume (Units), from 2003 to 2017 75
VI. 3 Drug Delivery Devices, Mexico, Distribution Channel (2009-2010) 80
VI. 3.1 Central Venous Catheters, Mexico, Distribution Channel (2009-2010) 80
VI. 3.2 Infusion Systems, Mexico, Distribution Channel (2009-2010) 80
VI. 3.3 Metered Dose Inhaler Devices, Mexico, Distribution Channel (2009-2010) 81
VI. 3.4 Needle Free Injections, Mexico, Distribution Channel (2009-2010) 81
VI. 4 Drug Delivery Devices, Mexico, Market Shares (2009-2010) 82
VI. 4.1 Drug Delivery Devices, Mexico, Market Shares (2009-2010) 82
VI. 4.2 Central Venous Catheters, Mexico, Market Shares (2009-2010) 84
VI. 4.3 Infusion Systems, Mexico, Market Shares (2009-2010) 86
VI. 4.4 Metered Dose Inhaler Devices, Mexico, Market Shares (2009-2010) 88
VI. 4.5 Needle Free Injections, Mexico, Market Shares (2009-2010) 90

VII Overview of Key Firms in South and Central America Drug Delivery Devices March ket 91
VII. 1 GlaxoSmithKline plc 91
VII. 1.1 Company Profile 91
VII. 1.2 Share in the South and Central America Drug Delivery Devices March ket 91
VII. 2 AstraZeneca International plc 92
VII. 2.1 Company Profile 92
VII. 2.2 Share in the South and Central America Drug Delivery Devices March ket 92
VII. 3 Boehringer Ingelheim GmbH 93
VII. 3.1 Company Profile 93
VII. 3.2 Share in the South and Central America Drug Delivery Devices March ket 93
VII. 4 Baxter International Inc. 94
VII. 4.1 Company Profile 94
VII. 4.2 Share in the South and Central America Drug Delivery Devices March ket 94
VII. 5 Hospira, Inc. 95
VII. 5.1 Company Profile 95
VII. 5.2 Share in the South and Central America Drug Delivery Devices March ket 95
VII. 6 B. Braun Melsungen AG 96
VII. 6.1 Company Profile 96
VII. 6.2 Share in the South and Central America Drug Delivery Devices March ket 96
VII. 7 Fresenius Kabi AG 97
VII. 7.1 Company Profile 97
VII. 8 Teleflex Incorporated 97
VII. 8.1 Company Profile 97
VII. 9 Medtronic, Inc. 97
VII. 9.1 Company Profile 97
VII. 10 Terumo Corporation 98
VII. 10.1 Company Profile 98
VII. 11 Smiths Medical 98
VII. 11.1 Company Profile 98
VII. 12 JMS CO., LTD. 98
VII. 12.1 Company Profile 98
VII. 13 3M Health Care 99
VII. 13.1 Company Profile 99
VII. 14 CareFusion Corporation 99
VII. 14.1 Company Profile 99
VII. 15 NIPRO CORPORATION 99
VII. 15.1 Company Profile 99
VII. 16 Arcomed A.G. Medical Systems 100
VII. 16.1 Company Profile 100
VII. 17 Consort Medical plc 100
VII. 17.1 Company Profile 100
VII. 18 Edwards Lifesciences Corporation 100
VII. 18.1 Company Profile 100
VII. 19 Becton, Dickinson and Firms 101
VII. 19.1 Company Profile 101
VII. 20 Cook Medical Incorporated 101
VII. 20.1 Company Profile 101
VII. 21 INJEX - Equidyne Systems 101
VII. 21.1 Company Profile 101
VII. 22 Bioject Medical Technologies Inc. 102
VII. 22.1 Company Profile 102

VIII Drug Delivery Devices March ket Pipeline Products 103

IX Appendix 107
IX. 1 Definitions of March kets Covered in the Report 108
IX. 1.1 Drug Delivery Devices 108
IX. 2 Research Methodology 109
IX. 3 Secondary Research 109
IX. 4 Primary Research 110
IX. 5 Models 110
IX. 6 Forecasted data s 111
IX. 7 Expert Panels 111
IX. 8 GlobalData Consulting 111
IX. 9 Currency Conversion 112
IX. 10 Contact Us 112
IX. 11 Disclaimer 112

1.1

List of Tables


Data table 1: Drug Delivery Devices, Cross Country Comparison, Sales (USD Million), from 2003 to 2017 11
Data table 2: Drug Delivery Devices, South and Central America, Overall Sales (USD Million), from 2003 to 2017 13
Data table 3: Drug Delivery Devices, South and Central America, Cross-Category Analysis, from 2003 to 2017 14
Data table 4: Drug Delivery Devices, South and Central America, Overall Sales (USD Million), Historical data, from 2003 to 2010 16
Data table 5: Drug Delivery Devices, South and Central America, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 18
Data table 6: Drug Delivery Devices, South and Central America, Segment Volume (Units), from 2003 to 2017 19
Data table 7: Drug Delivery Devices, South and Central America, Segment Volume (Units), Historical data, from 2003 to 2010 21
Data table 8: Drug Delivery Devices, South and Central America, Segment Volume (Units), Forecasted data, from 2010 to 2017 23
Data table 9: Drug Delivery Devices, South and Central America, Firms share by Sales (USD Million), from 2009 to 2010 25
Data table 10: Drug Delivery Devices, Argentina, Overall Sales (USD Million), from 2003 to 2017 27
Data table 11: Drug Delivery Devices, Argentina, Overall Sales (USD Million), Historical data, from 2003 to 2010 29
Data table 12: Drug Delivery Devices, Argentina, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 31
Data table 13: Drug Delivery Devices, Argentina, Segment Volume (Units), from 2003 to 2017 32
Data table 14: Drug Delivery Devices, Argentina, Segment Volume (Units), Historical data, from 2003 to 2010 34
Data table 15: Drug Delivery Devices, Argentina, Segment Volume (Units), Forecasted data, from 2010 to 2017 36
Data table 16: Central Venous Catheters, Argentina, Distribution Channel by Sales (USD Million), from 2009 to 2010 37
Data table 17: Infusion Systems, Argentina, Distribution Channel by Sales (USD Million), from 2009 to 2010 37
Data table 18: Metered Dose Inhaler Devices, Argentina, Distribution Channel by Sales (USD Million), from 2009 to 2010 38
Data table 19: Needle Free Injections, Argentina, Distribution Channel by Sales (USD Million), from 2009 to 2010 38
Data table 20: Drug Delivery Devices, Argentina, Market Shares by Sales (USD Million), from 2009 to 2010 40
Data table 21: Central Venous Catheters, Argentina, Market Shares by Sales (USD Million), from 2009 to 2010 42
Data table 22: Infusion Systems, Argentina, Market Shares by Sales (USD Million), from 2009 to 2010 44
Data table 23: Metered Dose Inhaler Devices, Argentina, Market Shares by Sales (USD Million), from 2009 to 2010 46
Data table 24: Needle Free Injections, Argentina, Market Shares by Sales (USD Million), from 2009 to 2010 47
Data table 25: Drug Delivery Devices, Brazil, Overall Sales (USD Million), from 2003 to 2017 49
Data table 26: Drug Delivery Devices, Brazil, Overall Sales (USD Million), Historical data, from 2003 to 2010 51
Data table 27: Drug Delivery Devices, Brazil, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 53
Data table 28: Drug Delivery Devices, Brazil, Segment Volume (Units), from 2003 to 2017 54
Data table 29: Drug Delivery Devices, Brazil, Segment Volume (Units), Historical data, from 2003 to 2010 56
Data table 30: Drug Delivery Devices, Brazil, Segment Volume (Units), Forecasted data, from 2010 to 2017 58
Data table 31: Central Venous Catheters, Brazil, Distribution Channel by Sales (USD Million), from 2009 to 2010 59
Data table 32: Infusion Systems, Brazil, Distribution Channel by Sales (USD Million), from 2009 to 2010 59
Data table 33: Metered Dose Inhaler Devices, Brazil, Distribution Channel by Sales (USD Million), from 2009 to 2010 60
Data table 34: Needle Free Injections, Brazil, Distribution Channel by Sales (USD Million), from 2009 to 2010 60
Data table 35: Drug Delivery Devices, Brazil, Market Shares by Sales (USD Million), from 2009 to 2010 62
Data table 36: Central Venous Catheters, Brazil, Market Shares by Sales (USD Million), from 2009 to 2010 64
Data table 37: Infusion Systems, Brazil, Market Shares by Sales (USD Million), from 2009 to 2010 66
Data table 38: Metered Dose Inhaler Devices, Brazil, Market Shares by Sales (USD Million), from 2009 to 2010 67
Data table 39: Needle Free Injections, Brazil, Market Shares by Sales (USD Million), from 2009 to 2010 68
Data table 40: Drug Delivery Devices, Mexico, Overall Sales (USD Million), from 2003 to 2017 70
Data table 41: Drug Delivery Devices, Mexico, Overall Sales (USD Million), Historical data, from 2003 to 2010 72
Data table 42: Drug Delivery Devices, Mexico, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 74
Data table 43: Drug Delivery Devices, Mexico, Segment Volume (Units), from 2003 to 2017 75
Data table 44: Drug Delivery Devices, Mexico, Segment Volume (Units), Historical data, from 2003 to 2010 77
Data table 45: Drug Delivery Devices, Mexico, Segment Volume (Units), Forecasted data, from 2010 to 2017 79
Data table 46: Central Venous Catheters, Mexico, Distribution Channel by Sales (USD Million), from 2009 to 2010 80
Data table 47: Infusion Systems, Mexico, Distribution Channel by Sales (USD Million), from 2009 to 2010 80
Data table 48: Metered Dose Inhaler Devices, Mexico, Distribution Channel by Sales (USD Million), from 2009 to 2010 81
Data table 49: Needle Free Injections, Mexico, Distribution Channel by Sales (USD Million), from 2009 to 2010 81
Data table 50: Drug Delivery Devices, Mexico, Market Shares by Sales (USD Million), from 2009 to 2010 83
Data table 51: Central Venous Catheters, Mexico, Market Shares by Sales (USD Million), from 2009 to 2010 85
Data table 52: Infusion Systems, Mexico, Market Shares by Sales (USD Million), from 2009 to 2010 87
Data table 53: Metered Dose Inhaler Devices, Mexico, Market Shares by Sales (USD Million), from 2009 to 2010 89
Data table 54: Needle Free Injections, Mexico, Market Shares by Sales (USD Million), from 2009 to 2010 90
Data table 55: Drug Delivery Devices March ket Pipeline Products 103
Data table 56: US Dollar to Local Currency, South and Central America, Average Exchange Rate from 2003 to 2010 112

1.2

List of Figures


Chart 1: Drug Delivery Devices, Cross Country Comparison, Sales (USD Million), from 2003 to 2017 11
Chart 2: Drug Delivery Devices, South and Central America, Overall Sales (USD Million), from 2003 to 2017 12
Chart 3: Drug Delivery Devices, South and Central America, Cross-Category Analysis, from 2003 to 2017 14
Chart 4: Drug Delivery Devices, South and Central America, Overall Sales (USD Million), Historical data, from 2003 to 2010 15
Chart 5: Drug Delivery Devices, South and Central America, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 17
Chart 6: Drug Delivery Devices, South and Central America, Segment Volume (Units), from 2003 to 2017 19
Chart 7: Drug Delivery Devices, South and Central America, Segment Volume (Units), Historical data, from 2003 to 2010 20
Chart 8: Drug Delivery Devices, South and Central America, Segment Volume (Units), Forecasted data, from 2010 to 2017 22
Chart 9: Drug Delivery Devices, South and Central America, Firms share (%), 2010 24
Chart 10: Drug Delivery Devices, Argentina, Overall Sales (USD Million), from 2003 to 2017 26
Chart 11: Drug Delivery Devices, Argentina, Overall Sales (USD Million), Historical data, from 2003 to 2010 28
Chart 12: Drug Delivery Devices, Argentina, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 30
Chart 13: Drug Delivery Devices, Argentina, Segment Volume (Units), from 2003 to 2017 32
Chart 14: Drug Delivery Devices, Argentina, Segment Volume (Units), Historical data, from 2003 to 2010 33
Chart 15: Drug Delivery Devices, Argentina, Segment Volume (Units), Forecasted data, from 2010 to 2017 35
Chart 16: Drug Delivery Devices, Argentina, Market Shares (%), 2010 39
Chart 17: Central Venous Catheters, Argentina, Market Shares (%), 2010 41
Chart 18: Infusion Systems, Argentina, Market Shares (%), 2010 43
Chart 19: Metered Dose Inhaler Devices, Argentina, Market Shares (%), 2010 45
Chart 20: Needle Free Injections, Argentina, Market Shares (%), 2010 47
Chart 21: Drug Delivery Devices, Brazil, Overall Sales (USD Million), from 2003 to 2017 48
Chart 22: Drug Delivery Devices, Brazil, Overall Sales (USD Million), Historical data, from 2003 to 2010 50
Chart 23: Drug Delivery Devices, Brazil, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 52
Chart 24: Drug Delivery Devices, Brazil, Segment Volume (Units), from 2003 to 2017 54
Chart 25: Drug Delivery Devices, Brazil, Segment Volume (Units), Historical data, from 2003 to 2010 55
Chart 26: Drug Delivery Devices, Brazil, Segment Volume (Units), Forecasted data, from 2010 to 2017 57
Chart 27: Drug Delivery Devices, Brazil, Market Shares (%), 2010 61
Chart 28: Central Venous Catheters, Brazil, Market Shares (%), 2010 63
Chart 29: Infusion Systems, Brazil, Market Shares (%), 2010 65
Chart 30: Metered Dose Inhaler Devices, Brazil, Market Shares (%), 2010 67
Chart 31: Needle Free Injections, Brazil, Market Shares (%), 2010 68
Chart 32: Drug Delivery Devices, Mexico, Overall Sales (USD Million), from 2003 to 2017 69
Chart 33: Drug Delivery Devices, Mexico, Overall Sales (USD Million), Historical data, from 2003 to 2010 71
Chart 34: Drug Delivery Devices, Mexico, Overall Sales (USD Million), Forecasted data, from 2010 to 2017 73
Chart 35: Drug Delivery Devices, Mexico, Segment Volume (Units), from 2003 to 2017 75
Chart 36: Drug Delivery Devices, Mexico, Segment Volume (Units), Historical data, from 2003 to 2010 76
Chart 37: Drug Delivery Devices, Mexico, Segment Volume (Units), Forecasted data, from 2010 to 2017 78
Chart 38: Drug Delivery Devices, Mexico, Market Shares (%), 2010 82
Chart 39: Central Venous Catheters, Mexico, Market Shares (%), 2010 84
Chart 40: Infusion Systems, Mexico, Market Shares (%), 2010 86
Chart 41: Metered Dose Inhaler Devices, Mexico, Market Shares (%), 2010 88
Chart 42: Needle Free Injections, Mexico, Market Shares (%), 2010 90
Chart 43: GlaxoSmithKline plc, Market Shares (%), South and Central America Drug Delivery Devices March ket, 2010 91
Chart 44: AstraZeneca PLC, Market Shares (%), South and Central America Drug Delivery Devices March ket, 2010 92
Chart 45: Boehringer Ingelheim GmbH, Market Shares (%), South and Central America Drug Delivery Devices March ket, 2010 93
Chart 46: Baxter International Inc., Market Shares (%), South and Central America Drug Delivery Devices March ket, 2010 94
Chart 47: Hospira, Inc., Market Shares (%), South and Central America Drug Delivery Devices March ket, 2010 95
Chart 48: B. Braun Melsungen AG, Market Shares (%), South and Central America Drug Delivery Devices March ket, 2010 96

Companies Mentioned
GlaxoSmithKline plc
AstraZeneca International plc
Boehringer Ingelheim GmbH
Baxter International Inc.
Hospira, Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Teleflex Incorporated
Medtronic, Inc.
Terumo Corporation
Smiths Medical
JMS CO., LTD.
3M Health Care
CareFusion Corporation
NIPRO CORPORATION
Arcomed A.G. Medical Systems
Consort Medical plc
Edwards Lifesciences Corporation
Becton, Dickinson and Firms
Cook Medical Incorporated
INJEX - Equidyne Systems
Bioject Medical Technologies Inc.

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Pulmonary Drug Delivery Systems: Technologies and Global Markets

Pulmonary Drug Delivery Systems: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • May 2014
  • by BCC Research

Use this report to: - Receive a detailed analysis of the present and future global market for pulmonary drug delivery technologies. - Receive information on pulmonary drug delivery technologies currently ...

RNAi Drug Delivery : Technologies and Gobal Markets

RNAi Drug Delivery : Technologies and Gobal Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This BCC Research report provides an in-depth assessment of recent progress and future opportunities for RNA interference (RNAi) players in major therapeutic and drug delivery areas, including infectious ...

Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Nebulizers Market (Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • $ 4 795
  • Industry report
  • May 2014
  • by Transparency Market Research

nebulizer is a medical device used for the treatment of respiratory disorders (asthma, COPD and cystic fibrosis) that converts liquid medication into mist or aerosol. Thus, the medicine can easily reach ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.